Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 139.51 Million CNY | 1.57% |
| 2022 | 141.25 Million CNY | -13.67% |
| 2021 | 163.61 Million CNY | 111.45% |
| 2020 | 77.37 Million CNY | -64.49% |
| 2019 | 217.9 Million CNY | -11.94% |
| 2018 | 247.46 Million CNY | 21.06% |
| 2017 | 204.41 Million CNY | 45.34% |
| 2016 | 140.64 Million CNY | 4.15% |
| 2015 | 135.04 Million CNY | 35.99% |
| 2014 | 99.3 Million CNY | -24.82% |
| 2013 | 132.08 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 27.61 Million CNY | -3.63% |
| 2024 Q2 | 39.98 Million CNY | 44.82% |
| 2024 Q3 | 25.16 Million CNY | -37.06% |
| 2023 Q1 | 42.57 Million CNY | 69.05% |
| 2023 Q3 | 31.69 Million CNY | -21.82% |
| 2023 Q2 | 40.54 Million CNY | -4.77% |
| 2023 Q4 | 28.64 Million CNY | -9.62% |
| 2023 FY | 143.46 Million CNY | 1.57% |
| 2022 FY | 141.25 Million CNY | -13.67% |
| 2022 Q4 | 25.18 Million CNY | -26.05% |
| 2022 Q3 | 34.05 Million CNY | -23.3% |
| 2022 Q2 | 44.4 Million CNY | 18.05% |
| 2022 Q1 | 37.61 Million CNY | 1.9% |
| 2021 Q3 | 37.18 Million CNY | -14.4% |
| 2021 Q4 | 36.9 Million CNY | -0.73% |
| 2021 Q1 | 46.08 Million CNY | 324.87% |
| 2021 FY | 163.61 Million CNY | 111.45% |
| 2021 Q2 | 43.43 Million CNY | -5.75% |
| 2020 Q4 | -20.49 Million CNY | -168.35% |
| 2020 Q3 | 29.98 Million CNY | -27.18% |
| 2020 Q2 | 41.17 Million CNY | 54.16% |
| 2020 Q1 | 26.71 Million CNY | -50.54% |
| 2020 FY | 77.37 Million CNY | -64.49% |
| 2019 FY | 217.9 Million CNY | -11.94% |
| 2019 Q4 | 54 Million CNY | 78.99% |
| 2019 Q3 | 30.17 Million CNY | -67.05% |
| 2019 Q1 | 42.16 Million CNY | -34.05% |
| 2019 Q2 | 91.57 Million CNY | 117.17% |
| 2018 Q1 | 44.32 Million CNY | 48.72% |
| 2018 Q3 | 50.84 Million CNY | -42.47% |
| 2018 Q4 | 63.92 Million CNY | 25.74% |
| 2018 FY | 247.46 Million CNY | 21.06% |
| 2018 Q2 | 88.37 Million CNY | 99.39% |
| 2017 Q4 | 29.8 Million CNY | -64.3% |
| 2017 FY | 204.41 Million CNY | 45.34% |
| 2017 Q1 | 25.26 Million CNY | -39.83% |
| 2017 Q3 | 83.48 Million CNY | 26.76% |
| 2017 Q2 | 65.86 Million CNY | 160.71% |
| 2016 Q4 | 41.98 Million CNY | 37.23% |
| 2016 Q3 | 30.59 Million CNY | 0.0% |
| 2016 FY | 140.64 Million CNY | 4.15% |
| 2015 FY | 135.04 Million CNY | 35.99% |
| 2014 FY | 99.3 Million CNY | -24.82% |
| 2013 FY | 132.08 Million CNY | 0.0% |